Viking Therapeutics Inc. Watch

from S-8 12 pages The Plan Includes Two Components: A 423 Component and a Non-423 Component. the Company Intends (But Makes No Undertaking or Representation to Maintain) the 423 Component to Qualify as an Employee Stock Purchase Plan. the Provisions of the 423 Component, Accordingly, Will Be Construed in a Manner That Is Consistent With the Requirements of Section 423 of the Code. Except as Otherwise Provided in the Plan or Determined by the Board, the Non-423 Component Will Operate and Be Administered in the Same Manner as the 423 Component. (C) the Company, by Means of the Plan, Seeks to Retain the Services of Such Eligible Employees, to Secure and Retain the Services of New Employees and to Provide Incentives for Such Persons to Exert Maximum Efforts for the Success of the Company and Its Related Corporations. 2. Administration. (A) the Board Or, to the Extent Set Forth in Section 2(c), the Committee Will Administer the Plan. References Herein to the Board Shall Be Deemed to Refer to the Committee Except Where Context Dictates Otherwise. (B) the Board Will Have the Power, Subject To, and Within the Limitations Of, the Express Provisions of the Plan: (I) to Determine How and When Purchase Rights Will Be Granted and the Provisions of Each Offering (Which Need Not Be Identical)

from S-8 6 pages Viking Therapeutics, Inc. Restricted Stock Award Grant Notice

from S-8 6 pages Viking Therapeutics, Inc. Rsu Award Grant Notice

from S-8 7 pages Viking Therapeutics, Inc. Stock Option Grant Notice

from S-8 23 pages Plan Purpose. the Company, by Means of the Plan, Seeks to Secure and Retain the Services of Employees, Directors and Consultants, to Provide Incentives for Such Persons to Exert Maximum Efforts for the Success of the Company and Any Affiliate and to Provide a Means by Which Such Persons May Be Given an Opportunity to Benefit From Increases in Value of the Common Stock Through the Granting of Awards. (B) Available Awards. the Plan Provides for the Grant of the Following Awards: (I) Incentive Stock Options; (II) Nonstatutory Stock Options; (III) Sars; (IV) Restricted Stock Awards; (V) Rsu Awards; and (VI) Other Awards. (C) Adoption Date; Effective Date. the Plan Will Come Into Existence on the Adoption Date, but No Award May Be Granted Prior to the Effective Date. 2. Shares Subject to the Plan

from S-3ASR 45 pages Viking Therapeutics, Inc. Indenture Dated as of [ ] [ ] Trustee

from 10-K 5 pages Description of Securities of Viking Therapeutics, Inc

from 10-K 5 pages Description of Securities of Viking Therapeutics, Inc

from S-3 54 pages Viking Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20 Debt Securities

from 10-K 5 pages Description of Securities of Viking Therapeutics, Inc

from 10-K 5 pages Description of Securities of Viking Therapeutics, Inc

from S-3 54 pages Viking Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20 Debt Securities

from 8-K 19 pages Common Stock Purchase Warrant Viking Therapeutics, Inc

from 8-K 18 pages Registration Rights Agreement

from S-3 54 pages Viking Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20 Debt Securities

from 8-K 15 pages Viking Therapeutics, Inc. Warrant to Purchase Common Stock

from 8-K 22 pages Warrant Agreement

from S-1/A 21 pages Warrant Agreement

from S-1/A 16 pages Form of Representative’s Warrant

from S-1 2 pages Additional Abbreviations May Also Be Used Though Not in the Above List